InsiderTrades.com logo
JD Vance Predicts: Wall Street vs. Trump & Your Money
From Priority Gold   |   Ad
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Get your free guide NOW before it's too late.

UPB Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $34,000,000.00
Insider Selling (Last 12 Months): $0.00

Upstream Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Upstream Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Upstream Bio Share Price & Price History

Current Price: $18.01
Price Change: ▼ Price Decrease of -4.73 (-20.80%)
As of 11/20/2024 01:00 AM ET

This chart shows the closing price history over time for UPB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JD Vance Predicts: Wall Street vs. Trump & Your Money
From Priority Gold   |   Ad
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Get your free guide NOW before it's too late.

Upstream Bio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/15/2024Ai Upstream LlcMajor ShareholderBuy1,175,000$17.00$19,975,000.001,175,000View SEC Filing Icon  
10/15/2024Erez ChimovitsDirectorBuy825,000$17.00$14,025,000.004,554,873View SEC Filing Icon  
See Full Table
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share
From Darwin   |   Ad
The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.
👉[Click here to get your FREE report delivered instantly!]

SEC Filings (Institutional Ownership Changes) for Upstream Bio (NASDAQ:UPB)

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.
Read More on Upstream Bio

Today's Range

Now: $18.01
Low: $17.81
High: $23.36

50 Day Range

MA: N/A

52 Week Range

Now: $18.01
Low: $17.81
High: $29.46

Volume

455,696 shs

Average Volume

307,711 shs

Market Capitalization

$965.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Upstream Bio?

Upstream Bio's top insider shareholders include:
  1. Erez Chimovits (Director)
  2. Ai Upstream Llc (Major Shareholder)
Learn More about top insider investors at Upstream Bio.
JD Vance Predicts: Wall Street vs. Trump & Your Money
From Priority Gold   |   Ad
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Get your free guide NOW before it's too late.